Mesenchymal stem cell therapy for attenuation of scar formation during wound healing

Citations Over TimeTop 1% of 2012 papers

Abstract

Scars are a consequence of cutaneous wound healing that can be both unsightly and detrimental to the function of the tissue. Scar tissue is generated by excessive deposition of extracellular matrix tissue by wound healing fibroblasts and myofibroblasts, and although it is inferior to the uninjured skin, it is able to restore integrity to the boundary between the body and its environment. Scarring is not a necessary process to repair the dermal tissues. Rather, scar tissue forms due to specific mechanisms that occur during the adult wound healing process and are modulated primarily by the inflammatory response at the site of injury. Adult tissue-derived mesenchymal stem cells, which participate in normal wound healing, are trophic mediators of tissue repair. These cells participate in attenuating inflammation in the wound and reprogramming the resident immune and wound healing cells to favor tissue regeneration and inhibit fibrotic tissue formation. As a result, these cells have been considered and tested as a likely candidate for a cellular therapy to promote scar-less wound healing. This review identifies specific mechanisms by which mesenchymal stem cells can limit tissue fibrosis and summarizes recent in vivo studies where these cells have been used successfully to limit scar formation.

Related Papers

• Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar.(1995)
• → Myofibroblast progeny in wound biology and wound healing studies(2021)77 cited
• → Granulation tissue myofibroblasts during normal and pathological skin healing: The interaction between their secretome and the microenvironment(2021)52 cited
• → Time-dependent appearance of myofibroblasts in granulation tissue of human skin wounds(1992)40 cited
• Activity change of protein kinase A in TGF - p, accelerating wound healing of rabbit ear(2003)